IL6 and cancer: The proinflammatory cytokine IL-6 is commonly upregulated in various types of cancer including OSCC 44, and the elevated IL-6 level may promote nodal and distant metastasis by activating the PI3K/AKT/mTOR signaling pathway and correlate with cancer proliferation and poor survival 45.